Back to ABUS
VANGUARD GROUP INC ABUS Position History
Arbutus Biopharma Corporation
Quarters held
20
Latest value
$416K
Q4 2025
Peak value
$38.4M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $30.2M |
| Q1 2025 | $466K |
| Q1 2025 | $313K |
| Q1 2025 | $109K |
| Q1 2025 | $170K |
| Q2 2025 | $27.1M |
| Q2 2025 | $441K |
| Q2 2025 | $277K |
| Q2 2025 | $97K |
| Q2 2025 | $173K |
| Q3 2025 | $142K |
| Q3 2025 | $254K |
| Q3 2025 | $4.5M |
| Q3 2025 | $35.5M |
| Q3 2025 | $407K |
| Q4 2025 | $38.4M |
| Q4 2025 | $5M |
| Q4 2025 | $431K |
| Q4 2025 | $150K |
| Q4 2025 | $416K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $416K | 86.4K | — | — |
| Q4 2025 | $150K | 31.3K | — | — |
| Q4 2025 | $431K | 89.6K | — | — |
| Q4 2025 | $5M | 1.05M | — | — |
| Q4 2025 | $38.4M | 7.99M | — | — |
| Q3 2025 | $407K | 89.6K | — | — |
| Q3 2025 | $35.5M | 7.81M | — | — |
| Q3 2025 | $4.5M | 1.00M | — | — |
| Q3 2025 | $254K | 55.9K | — | — |
| Q3 2025 | $142K | 31.3K | — | — |
| Q2 2025 | $173K | 55.9K | — | — |
| Q2 2025 | $97K | 31.3K | — | — |
| Q2 2025 | $277K | 89.6K | — | — |
| Q2 2025 | $441K | 142.6K | — | — |
| Q2 2025 | $27.1M | 8.77M | — | — |
| Q1 2025 | $170K | 48.8K | — | — |
| Q1 2025 | $109K | 31.3K | — | — |
| Q1 2025 | $313K | 89.6K | — | — |
| Q1 2025 | $466K | 133.4K | — | — |
| Q1 2025 | $30.2M | 8.65M | — | — |
Other funds holding ABUS
$119.1M
$119.1M
$109.8M
$103.4M
$103.4M
$91.7M
$83.5M